These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1235358)

  • 1. [Amikacin: a new semisynthetic aminoside antibiotic derivative of kanamycin A. Action spectrum].
    Periti P; Lamanna A; Nicoletti I; Mazzei T; Polito P
    G Ital Chemioter; 1975; 22(1-2):75-86. PubMed ID: 1235358
    [No Abstract]   [Full Text] [Related]  

  • 2. [Microbiological characteristics of kanendomycin].
    Blandino G; Mattina R; Speciale A; Toscano MA
    G Ital Chemioter; 1977; 24(1-2):7-10. PubMed ID: 615765
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sensitivity of gram-negative germs to Amikacin].
    Redjeb SB; Ennaifer M; Bissardon O; Ben Salah N; Boujnah A
    Tunis Med; 1979; 57(2-3):103-6. PubMed ID: 553336
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental study of the antibacterial activity and chemotherapeutic effectiveness of amikacin sulfate].
    Lobuseva AN; Kuznetsova SM; Samoĭlova LN
    Antibiot Med Biotekhnol; 1985 Oct; 30(10):776-80. PubMed ID: 4091515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of the microbiological activity in vitro of BB-K-8, a new aminoglycoside antibiotic].
    Ravagnan G; Rasura M; Piccolomini R
    Boll Soc Ital Biol Sper; 1976 Sep; 52(18):1440-6. PubMed ID: 1024552
    [No Abstract]   [Full Text] [Related]  

  • 6. The susceptibility of recently isolates of gram-negative bacteria to amikacin and other aminoglycosides.
    Lexomboon U; Duangmani C; Srimunta C
    J Med Assoc Thai; 1979 Oct; 62(10):544-9. PubMed ID: 501262
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro susceptibility of gram negative bacteria to amikacin and its comparison with three other aminoglycoside antibiotics.
    Daniel J; Thomas M; Shanmugam J
    Indian J Pathol Microbiol; 1985 Apr; 28(2):115-9. PubMed ID: 3835114
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial spectrum, pharmacology, adverse effects, and therapeutic use of amikacin sulfate.
    Pien FD; Ho PW
    Am J Hosp Pharm; 1981 Jul; 38(7):981-9. PubMed ID: 7020413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the in vitro antibacterial activities of homemade amikacin on the common bacterial pathogens].
    Wang QN; Jiang YF; Du JZ; Luo MY; Liu YH; Xu ZM
    Yao Xue Xue Bao; 1982 May; 17(5):321-6. PubMed ID: 7180464
    [No Abstract]   [Full Text] [Related]  

  • 10. [The antibacterial activity of amikacin in comparison with four other aminoglycoside antibiotics (proceedings)].
    Schassan HH
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):320-8. PubMed ID: 983520
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative study of Amikacin (BB-K8) and gentamicin activity in vitro against Proteus rettgeri.
    Pérez-Rodríguez F; Bermúdez RH; de Brau CJ
    Bol Asoc Med P R; 1977 Jul; 69(7):222-6. PubMed ID: 268183
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
    Cuena Boy R; Azanza Perea JR; Echeverría Echepare LM; Honorato Pérez J
    Rev Med Univ Navarra; 1983 Dec; 27(4):21-7. PubMed ID: 6676898
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and microbiologic consequences of amikacin use during a 42-month period.
    Berk SL; Alvarez S; Ortega G; Verghese A; Holtsclaw-Berk SA
    Arch Intern Med; 1986 Mar; 146(3):538-41. PubMed ID: 3954526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aspects of antibacterial therapy using amikacin].
    Grassi GG; Bucci R; Ferrara A
    G Ital Chemioter; 1976; 23(1):47-54. PubMed ID: 1029696
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possible errors in the interpretation of bacterial sensitivity to aminoglycoside antibiotics].
    García Hierro P; Ponte Miramontes MC; Soriano García F
    Rev Clin Esp; 1980 Oct; 159(2):87-90. PubMed ID: 7209044
    [No Abstract]   [Full Text] [Related]  

  • 16. Amikacin.
    Lancet; 1975 Oct; 2(7939):804-5. PubMed ID: 78162
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory and clinical studies on amikacin.
    Wang QN; Du JZ; Liu YH; Jiang YF; Sheng JQ; Qiu ZD; Luo MY
    Chin Med J (Engl); 1985 Nov; 98(11):807-16. PubMed ID: 3938711
    [No Abstract]   [Full Text] [Related]  

  • 18. Laboratory evaluation of amikacin susceptibility testing by the AutoBac I system.
    Boughton WH; Berman SJ; Boughton MT
    J Clin Microbiol; 1979 Mar; 9(3):397-8. PubMed ID: 457852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amikacin sulfate.
    Hefelfinger DC
    JAMA; 1978 Mar; 239(10):930-1. PubMed ID: 628036
    [No Abstract]   [Full Text] [Related]  

  • 20. [Control of the resistance of gram-negative bacilli to aminoglucosides. Results of a 3-year prospective study with the exclusive use of amikacin].
    Ruiz-Palacios G; Ponce de León S; Sifuentes J; Ponce de León S; Calva J; Huazano F; Ontiveros C; Ojeda F; Bobadilla M
    Rev Invest Clin; 1986; 38(1):1-6. PubMed ID: 3738260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.